Oral and Posters
* Please scroll horizontally to see the table.
| Abstract No. | Session | Category | Abstract title | Name | Affiliation |
|---|---|---|---|---|---|
| Y-001 | Young Investigator Award (Oral Presentaiton) | Basic science | Human trophoblast development is captured by naive induced pluripotent stem cells in vitro | Dr. Shingo Io | Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Japan |
| Y-002 | Young Investigator Award (Oral Presentaiton) | Basic science | Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney COMT activity | Dr. Asako Kumagai | The department of Obstetrics and Gynecology, Juntendo University, Japan |
| Y-003 | Young Investigator Award (Oral Presentaiton) | Basic science | Longitudinal serum cytokine profiles in gestational hypertension and preeclampsia | Dr. Anders H. Jarmund | Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway |
| Y-004 | Young Investigator Award (Oral Presentaiton) | Basic science | Investigating nitrate metabolism and the oral microbiome in hypertensive pregnancies | Dr. Thomas Willmott | University of Manchester, UK |
| Y-005 | Young Investigator Award (Oral Presentaiton) | Basic science | "Altered placental morphology results in impaired fetal organ development in hsFLT1-transgenic mice: first signs of fetal programming in preeclampsia?" | Dr. Rebekka Vogtmann | Department of Gynecology and Obstetrics, University Hospital Essen, Germany |
| Y-006 | Young Investigator Award (Oral Presentaiton) | Prediction | Predicting algorithm for risk of pre-eclampsia using 1st trimester circulating microRNAs. | Dr. Andrée-Anne Clément | " Département de biochimie et de génomique fonctionnelle, Université de Sherbrooke, Sherbrooke, Québec, Canada" |
| Y-007 | Young Investigator Award (Oral Presentaiton) | Prediction | Is the cut-off 38 the best value to predict adverse outcomes in pregnancies with abnormal uterine artery doppler In the second trimestre? | Dr. Sara Caamina Alvarez | Department of Obstetrics. University Hospital NTRA SRA De Candelaria. Santa Cruz Tenerife, Spain |
| Y-008 | Young Investigator Award (Oral Presentaiton) | Prediction | Accurate prediction of total PlGF from free PlGF and sFlt-1: Evidence for markedly elevated PlGF levels in acute fatty liver of pregnancy | Dr. Rugina I. Neuman | Department of Internal Medicine; Division of Pharmacology and Vascular Medicine, Erasmus MC University Hospital, Rotterdam, The Netherlands |
| Y-009 | Young Investigator Award (Oral Presentaiton) | Prediction | The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia | Dr. Johanne J. Rakner | Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway |
| Y-010 | Young Investigator Award (Oral Presentaiton) | Prediction | Prediction of hypertensive disorders of pregnancy based on home blood pressure monitoring | Dr. Shuntaro Ohno | Graduate School of Medicine and Pharmaceutical Sciences for Education, University of Toyama, Japan |
| Y-011 | Young Investigator Award (Oral Presentaiton) | Therapy | Comparison 0f zuspan regime and its 12-hour modification in women with severe pre-eclampsia and eclampsia In two hospitals In Abeokuta, South Western Nigeria | Dr. Elizabeth O. Grillo | Department of Obstetrics and Gynaecology, Federal Medical Centre, Abeokuta, Ogun State, Nigeria |
| Y-012 | Young Investigator Award (Oral Presentaiton) | Therapy | Metformin changes serum cytokines in pregnant women with polycystic ovary syndrome | Dr. Mariell Ryssdal | Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway |
| Y-013 | Young Investigator Award (Oral Presentaiton) | Therapy | The effect of COVID-19 on placental function: a population level and case-control study | Dr. Michael Wilkinson | Maternal & Fetal Health Research Centre, University of Manchester, UK |
| Y-014 | Young Investigator Award (Oral Presentaiton) | Neonatal outcomes | Two-year infant and maternal outcomes after planned delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial | Dr. Alice Beardmore-Gray | Department of Women and Children's Health, School of Life Course Sciences, King's College London, UK |
| Y-015 | Young Investigator Award (Oral Presentaiton) | Neonatal outcomes | Hypertensive disorders of pregnancy and alterations in brain metabolites in preterm infants: a multi-voxel proton MR spectroscopy study | Dr. Satoru Katsuki | Department of Obstetrics and Gynecology, Graduate School of Medicine, Nagoya University, Japan |
| Y-016 | Young Investigator Award (Oral Presentaiton) | Chronic hypertension | Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy | Dr. Inger B. Ragnarsdottir | Department of Women´s and Children´s Health, Uppsala University, Sweden |
| Y-017 | Young Investigator Award (Oral Presentaiton) | Care prevention | "SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study" | Dr. Josephus F.M. van den Heuvel | University Medical Center Utrecht, The Netherlands |
| Y-018 | Young Investigator Award (Poster Presentation) | Basic science | Placental-derived human sFLT1 accumulates in maternal serum and alters placental and fetal development in transgenic mice | Dr. Rebekka Vogtmann | Department of Gynecology and Obstetrics, University Hospital Essen, Germany |
| Y-019 | Young Investigator Award (Poster Presentation) | Immunology | Immunomodulatory effect of vitamin D on the activators of transcription and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia | Dr. Vanessa R Ribeiro | Botucatu Medical School, Sao Paulo State University-UNESP, Brazil |
| O-001 | Oral Presentation | Basic science | Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs | Dr. Adelene Y. Tan | Aggamin, New York NY, USA |
| O-002 | Oral Presentation | Basic science | Beneficial Role of sodium nitrate on pregnancy in mice lacking eNOS | Dr. Nobuyuki Takahashi | Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Japan |
| O-003 | Oral Presentation | Basic science | Roles of histidine-rich glycoprotein in prevention of hypertensive disorders of pregnancy and in physiological placental development. | Dr. Kiyoshi Teshigawara | Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences., Japan |
| O-004 | Oral Presentation | Prediction | Circulating SIGLEC6 is deranged in preeclampsia and may be a biomarker of disease severity | Dr. Tu'uhevaha J Kaitu'u-Lino | Department of Obstetrics and Gynaecology, University of Melbourne, Victoria, Australia |
| O-005 | Oral Presentation | Prediction | Circulating biomarkers for neurological complications in preeclampsia | Dr. Lina Bergman | Institute of clinical sciences, Department of obstetrics and Gynecology, Sahlgrenska Academy, Gothenburg University, Sweden |
| O-006 | Oral Presentation | Therapy | Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with eclampsia or imminent eclampsia | Dr. Jose C Peracoli | Botucatu Medical School, Sao Paulo State University, UNESP, Brazil |
| O-007 | Oral Presentation | Therapy | Beneficial effect of Protease-activated receptor 2 (PAR2) on pregnancy | Dr. Nobuyuki Takahashi | Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Japan |
| O-008 | Oral Presentation | Neonatal outcomes | Influence of Hypertension in Pregnancy on Hematological Phenotypes of Preterm Infants with Gestational Age Inferior to 32 Weeks | Dr. Mariza Martins | Departamento de Oftalmologia do Hospital Cuf Descobertas, Portugal |
| O-009 | Oral Presentation | Neonatal outcomes | Intrauterine exposure to hypertensive disorders of pregnancy and postnatal growth in extremely and very preterm infants | Dr. Takafumi Ushida | Department of Obstetrics and Gynecology, Nagoya University, Japan |
| O-010 | Oral Presentation | Chronic hypertension, GH | Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy | Dr. Sho Tano | Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Japan |
| O-011 | Oral Presentation | Care and prevention | Pre-pregnancy stress leads to impaired placental development, post-partum high blood pressure and vascular dysfunction | Dr. Robert W. Powers | Magee-Womens Research Institute, USA |
| P-001 | Poster Presentation | Basic science | AI_PREMie: a novel risk stratification tool for preeclamptic-toxaemia. | Dr. Paulina B. Szklanna | ConwaySPHERE Research Group, UCD Conway Institute, University College Dublin, Dublin 4, Ireland |
| P-002 | Poster Presentation | Basic science | Evidence of neuroinflammation and injured blood-brain-barrier in eclampsia | Dr. Lina Bergman | Institute of clinical sciences, Department of obstetrics and Gynecology, Sahlgrenska Academy, Gothenburg University, Sweden |
| P-003 | Poster Presentation | Basic science | Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction | Dr. Tatsuya Matsuyama | Osaka University Graduate School of Medicine, Japan |
| P-004 | Poster Presentation | Basic science | A novel use of β3 adrenergic receptor agonist in treating preeclampsia | Dr. Chia-chi Liu | Vascular Immunology Research Laboratory, The Heart Research Institute, University of Sydney, Australia |
| P-005 | Poster Presentation | Basic science | Involvement of RAGE pathway in visceral adipose tissue in preeclampsia | Dr. Juria Akasaka | Department of Obstetrics and Gynecology, Nara Medical University, Japan |
| P-006 | Poster Presentation | Basic science | The pathophysiological role of calreticulin in maternal circulation for preeclampsia | Dr. Naoyuki Iwahashi | Department of Obstetrics and Gynecology, Wakayama Medical University, Japan |
| P-007 | Poster Presentation | Basic science | Are there differences in the decidualizing endometrial secretome in women with recurrent pre-eclampsia? | Dr. Olivia C. Moran | Maternal and Fetal Health Research Centre, University of Manchester, UK |
| P-008 | Poster Presentation | Biomarkers and risk factors | Predictive efficacy of sFlt-1/PlGF ratio in risk stratification on Indian hypertensive pregnant population | Dr. Prerana Nagabhushana | The Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India |
| P-009 | Poster Presentation | Biomarkers and risk factors | Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia. | Dr. Roxanne Hastie | Department of Obstetrics and Gynaecology, University of Melbourne, Australia |
| P-010 | Poster Presentation | Biomarkers and risk factors | Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio in pregnant women with suspected preeclampsia | Dr. Tomomi Yamazaki | Depertment of Obstetrics and Gynecology, Hiroshima University Hospital, Japan |
| P-011 | Poster Presentation | Biomarkers and risk factors | sFLT-1, PLGF e sFLT-1 / PLGF levels in preeclampsia: correlation with mediated maternal results | Dr. Ademar P. S. Filho | Centro Universitario Lusiada, Brazil |
| P-012 | Poster Presentation | Biomarkers and risk factors | The association of sFlt-1: PlGF ratio with systematic damage in patient at increased risk of hypertensive disorders during pregnancy | Dr. Di Mao | Guangzhou Women and Children's Medical Center, China |
| P-013 | Poster Presentation | Biomarkers and risk factors | Negative predictive value of sFlt-1/PlGF ratio ≤38 for ruling out preeclampsia within 1-4 weeks of testing: a secondary analysis of the INSPIRE trial | Dr. A. Sofia Cerdeira | Nuffield Department of Women’s Health and Reproductive Research, University of Oxford, Oxford, UK |
| P-014 | Poster Presentation | Biomarkers and risk factors | Role of sFlt-1/PlGF as a predictor of small for gestational age | Dr. Selina Chiu | Northwick Park Hospital, London North West University Healthcare NHS Trust, UK |
| P-015 | Poster Presentation | Biomarkers and risk factors | Withdraw | ||
| P-016 | Poster Presentation | Biomarkers and risk factors | Sub-analysis of the Japanese population from PROGNOSIS Asia study assessing the sFlt-1/PlGF ratio for short-term prediction of preeclampsia | Dr. Akihide Ohkuchi | Jichi Medical University Hospital, Tochigi, Japan |
| P-017 | Poster Presentation | Biomarkers and risk factors | The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: economic evaluation | Dr. Akihide Ohkuchi | Jichi Medical University Hospital, Tochigi, Japan, |
| P-018 | Poster Presentation | Biomarkers and risk factors | Analysis of subpopulation of exosomes in prospective samples before the onset of preeclampsia | Dr. Ayako Hashimoto | School of Life Science and Technology, Tokyo Institute of Technology, Japan |
| P-019 | Poster Presentation | Biomarkers and risk factors | Pre-pregnancy maternal stress leads to impaired vascular function during pregnancy | Dr. Robert W. Powers | Obstetrics & Gynecology and Reproductive Sciences, USA |
| P-020 | Poster Presentation | Biomarkers and risk factors | The relationship of the parameter of ambulatory blood pressure monitoring and bio-marker in women with hypertensive disorders of pregnancy | Dr. Xiaodan Di | Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China |
| P-021 | Poster Presentation | Biomarkers and risk factors | Correlation between cognitive assessment scores and circulating cerebral biomarkers in women with preeclampsia and eclampsia | Dr. Emma Bokström-Rees | Department of Obstetrics and Gynecology, Institute of clinical sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden |
| P-022 | Poster Presentation | Biomarkers and risk factors | Effects of arginase genetic polymorphisms on nitric oxide formation in responsive and nonresponsive preeclampsia women | Dr. Caroline C. Pinto-Souza | Department of Biophysics and Pharmacology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Distrito Rubiao Junior, Botucatu, Brazil |
| P-023 | Poster Presentation | Biomarkers and risk factors | Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy. | Dr. Ricardo Cavalli | Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Brazil |
| P-024 | Poster Presentation | Biomarkers and risk factors | Association between office blood pressure levels at 11-13 weeks gestation and the development of hypertension requiring treatment | Dr. Keiko Koide | Department of Obstetrics and Gynecology, Showa University School of Medicine, Japan |
| P-025 | Poster Presentation | Biomarkers and risk factors | Comparison of methods for determining PlGF and sFlt-1 levels in maternal circulation in pregnancies complicated by placental dysfunction | Dr. Kirsty M.M. Vincent | Maternal & Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK |
| P-026 | Poster Presentation | Biomarkers and risk factors | Association between vascular remodeling biomarkers and the placentary bed in pre-eclampsy | Dr. Beatriz R. B. Damasceno | Centro Universitario Lusiada, Brazil |
| P-027 | Poster Presentation | Biomarkers and risk factors | The prognostic role of maternal angiogenic markers in suspected pre-eclampsia in twin pregnancies | Dr. Melinda Pattanasri | Dept Maternal Fetal Medicine, Royal Women's Hospital (RWH), Melbourne, Australia |
| P-028 | Poster Presentation | Biomarkers and risk factors | Study of mean platelet volume in first trimester of pregnancy and its association with development of preeclampsia | Dr. Vandana Solanki | Department of OB/GYN, KGMU, Lucknow, uttar pradesh , India |
| P-029 | Poster Presentation | Biomarkers and risk factors | Role of Placental growth factor for prediction of preeclampsia in first trimester of pregnancy | Dr. Verma Manju Lata Verma | King George Medical University, Lucknow , UP, India |
| P-030 | Poster Presentation | Immunology | Vitamin D modulates inflammasomes in placental explants of preeclamptic women and decreased apoptosis in huvec cultured Wwth monosodium rrate | Dr. Priscila R Nunes | Botucatu Medical School, Sao Paulo State University (Unesp), Brazil |
| P-031 | Poster Presentation | Immunology | Vitamin D maintains viability and decreases apoptosis in huvec and modulates inflammation in placenta from preeclamptic women cultured with TNF-α | Dr. Priscila R Nunes | Botucatu Medical School, Sao Paulo State University (Unesp), Brazil |
| P-032 | Poster Presentation | Immunology | Silibinin downregulates the expression of the Th1 and Th17 profiles by the modulation of STATs and transcription factors in pregnant women with preeclampsia | Dr. Vanessa R Ribeiro | Botucatu Medical School, Sao Paulo State University-UNESP, Brazil |
| P-033 | Poster Presentation | Immunology | Changes of natural cytotoxicity receptors of CD56dim and CD56bright NK cells in peripheral blood and decidua in preeclampsia | Dr. Tatsuo Yamamoto | Department of Obstetrics & Gynecology, Kasukabe medical center, Japan |
| P-034 | Poster Presentation | Immunology | Decreased circulating levels of plasmacytoid dendritic cells in women with early-onset preeclampsia | Dr. Shiho Nagayama | Department of Obstetrics and Gynecology, Jichi Medical University School of Medicine, Japan |
| P-035 | Poster Presentation | Epidemiology | Behavioral risk factors of cardiovascular diseases in pregnant women. prevalence and socioeconomic predictors in Burkina Faso: a cross-sectional study. | Dr. Garanet Franck | "Departement Santé Publique et Biomedical, Institut de Recherche en Sciences de la Santé;Université Ouaga1 Joseph Ki Zerbo, Laboratoire de Santé Publique, Burkina Faso" |
| P-036 | Poster Presentation | Epidemiology | Early onset hypertensive disorders of pregnancy is a high risk phenotype for placental abruption: A Japanese nationwide cohort study | Dr. Katsuhiko Naruse | Department of Obstetrics and Gynecology, Nara Medical University, Japan |
| P-037 | Poster Presentation | Epidemiology | Revisiting ‘3 delays model ' for critical analysis of hypertensive maternal mortality in a developing nation | Dr. Seema Mehrotra | Dept Of Obstetrics and Gynaecology,KGMU,Lucknow, India |
| P-038 | Poster Presentation | Translational research | A survey for the need and potential acceptance for AI-based decision support tools in Obstetric Medicine | Dr. Max Hackeloeer | Department of Obstetrics, Charité – Universitätsmedizin Berlin, Germany |
| P-039 | Poster Presentation | Translational research | Building clinically usable Machine-Learning models for outcome predicition in preeclampsia | Dr. Oliver S. Rieger | Charite, Berlin Institute of Health, Germany |
| P-040 | Poster Presentation | Translational research | Development of a Machine-Learning Model to predict adverse outcomes in patients at risk for preeclampsia | Dr. Leon J. Schmidt | Department of Obstetrics, Charité Universitätsmedizin Berlin, Germany |
| P-041 | Poster Presentation | Translational research | Data mining model as a prediction of pregnancy hypertension with decision tree technique algorithm | Dr. Rifaldy Fajar | Computational Biology Laboratory, Yogyakarta State University, Indonesia |
| P-042 | Poster Presentation | Preeclampsia | "Circulating sFLT1 is sufficient to impair spiral arterial remodeling in mice: dissecting the maternal and the placental contribution of preeclampsia" | Dr. Rebekka Vogtmann | Department of Gynecology and Obstetrics, University Hospital Essen, Germany |
| P-043 | Poster Presentation | Preeclampsia | Simvastatin attenuates the symptoms of preeclampsia murine model | Dr. Kei Inaba | Department of Obstetrics and Gynecology, The University of Tokyo, Japan |
| P-044 | Poster Presentation | Preeclampsia | Assessing long-term cardiovascular effects of hypertension in an L-NAME mouse model of preeclampsia | Dr. Natasha de Alwis | Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Australia |
| P-045 | Poster Presentation | Preeclampsia | VEGFR/SFlt1 is associated to disruption of oxidative stress leading to endothelial dysfunction in preeclampsia | Dr. Andreia Matos | Laboratório de Genética, Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal |
| P-046 | Poster Presentation | Preeclampsia | Intensive blood pressure control in chronically hypertensive mice | Dr. Mikala Welsh | Sydney Local Health District, Australia |
| P-047 | Poster Presentation | Preeclampsia | Elevated placental histone H3K4 methylation via upregulated histone methyltransferases in preeclampsia and its possible involvement in hypoxia-induced pathophysiology | Dr. Haruka Matsui | Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Japan |
| P-048 | Poster Presentation | Preeclampsia | Stringent laboratory monitoring of pre-eclampsia and gestational hypertension: improving care in low-resource settings | Dr. Nnabuike Chibuoke Ngene | Department of Obstetrics and Gynaecology, University of the Witwatersrand, South Africa |
| P-049 | Poster Presentation | Preeclampsia | The efficacy of discontinuing the use of low-dose aspirin at 28 weeks of gestation for preventing preeclampsia | Dr. Haruna Kawaguchi | Osaka Women’s and Children’s Hospital, Japan |
| P-050 | Poster Presentation | Preeclampsia | Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library | Dr. Kazunobu Yagi | Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan |
| P-051 | Poster Presentation | Preeclampsia | Retrospective study for classifying hypertensive disorders of pregnancy by time of onset | Dr. Eishin Nakamura | Center for Maternal, Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Japan |
| P-052 | Poster Presentation | Preeclampsia | Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia | Dr. Paliz Nordlöf Callbo | Department of Women’s and Children’s Health, Uppsala University, Sweden |
| P-053 | Poster Presentation | Preeclampsia | Association between fasting plasma glucose level at less than 24 weeks of gestation and hypertensive disorders of pregnancy: The BOSHI study | Dr. Seiya Izumi | Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan |
| P-054 | Poster Presentation | Preeclampsia | Maternal hemodynamics assessed by USCOM® device in patients with hypertensive disorders of pregnancy during peripartum | Dr. Junmin Zhong | Guangzhou Women and Children's Medical Center, China |
| P-055 | Poster Presentation | Preeclampsia | Erythropoietin expression on fetal red blood cells in preeclampsia | Dr. Vasiliy Chulkov | Faculty Therapy Department, South Ural State Medical University, Russia |
| P-056 | Poster Presentation | Preeclampsia | Profound changes in hemodynamics proving late-onset PE being of maternal origin | Dr. Kamilla T. Muminova | National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov Ministry of Healthcare of Russia, Russia |
| P-057 | Poster Presentation | Preeclampsia | Preeclampsia prediction based on urine peptidome study | Dr. Kamilla T. Muminova | Scientific Center for Obstetrics, Gynecology and Perinatology named after academician Kulakov, Moscow, Russia |
| P-058 | Poster Presentation | Preeclampsia | A comparison of the effects of placenta-derived extracellular vesicles from preeclamptic and uncomplicated pregnancies on endothelial-dependent vascular function | Dr. Roberto Villalobos-Labra | Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB, Canada |
| P-059 | Poster Presentation | Preeclampsia | Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy | Dr. Koh Nagata | Obstetrics and Gynecology, The University of Nagasaki, Japan |
| P-060 | Poster Presentation | Preeclampsia | adverse effects of the use of magnesium sulfate in a patient with preeclampsia | Dr. Marcela C. Malandrin | HOSPITAL ANA COSTA - SANTOS - SP - BRAZIL, Brazil |
| P-061 | Poster Presentation | Preeclampsia | Successful vaginal delivery in pregnant women with preeclampsia undergoing labor induction with Prostaglandin | Dr. Yuri R Sassatani | HOSPITAL ANA COSTA - SANTOS -SP-BRAZIL, Brazil |
| P-062 | Poster Presentation | Preeclampsia | Success of vaginal parturiation in pregnant women with preeclampsia submitted to induction of delivery after cervical ripening | Dr. Beatrzi G. Vettorazzo | Hospital Ana Costa de Santos, Brazil |
| P-063 | Poster Presentation | Preeclampsia | Pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of african ancestry | Dr. Nerolen Soobryan | 1Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Republic of South Africa |
| P-064 | Poster Presentation | Preeclampsia | The significance of chest X-ray abnormalities early in the third trimester of twin pregnancies, its relationship with develpoment of preeclampsia | Dr. Kazunobu Yagi | Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan |
| P-065 | Poster Presentation | Preeclampsia | New human models of preeclampsia; offering physiologically relevant assays for the development of therapeutics to ameliorate preeclamptic vascular dysfunction. | Dr. Bianca_R Fato | Therapeutics Discovery and Vascular Function Group, Australia |
| P-066 | Poster Presentation | Preeclampsia | Blood pressure as a risk factor for eclampsia and pulmonary oedema in pre-eclampsia | Dr. Pauli van Heerden | Department of Obstetrics and Gynaecology, Tygerberg Hospital, University of Stellenbosch, Cape Town, South Africa |
| P-067 | Poster Presentation | Preeclampsia | Biomarkers profiles of hypertensive disorders of pregnancy on term gestational period: revival of von Willebrand factor | Dr. Kiichiro Furuya | Department of Obstetrics and Gynecology, Rinku General Medical Center, Japan |
| P-068 | Poster Presentation | Preeclampsia | Fetal growth restriction in diagnosing preeclampsia is an important diagnostic criterion comparable to organ dysfunction | Dr. Naoya Akiba | The University of Tokyo Hospital Department of Obstetrics and Gynecology, Faculty of Medicine, Japan |
| P-069 | Poster Presentation | Preeclampsia | Planned delivery or expectant management for the prevention of adverse pregnancy outcomes in pre-eclampsia: a meta-analysis of individual participant data | Dr. Alice Beardmore-Gray | Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, UK |
| P-070 | Poster Presentation | Preeclampsia | Neonatal outcomes In pre-eclampsia: Correlation among clinical and laboratory maternal factors | Dr. Thais M. P. Souza | Centro Universitario Lusiada, Brazil |
| P-071 | Poster Presentation | Preeclampsia | Application of fullpiers as predictor of neonatal outcomes in pre-eclampsia | Dr. Luiza B. Gaspar | Centro Universitario Lusiada, Brazil |
| P-072 | Poster Presentation | Preeclampsia | Severe anemia and preeclampsia – case report and literature review | Dr. Ikuno Kawabata | Department of Obstetrics and Gynecology, Nippon Medical School, Japan |
| P-073 | Poster Presentation | Preeclampsia | A case of preeclampsia complicated with posterior reversible encephalopathy syndrome and central serous chorioretinopathy. | Dr. Naomi Seo | Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Japan |
| P-074 | Poster Presentation | Preeclampsia | Preeclampsia starting at 17 weeks of gestational age in a twin pregnancy: a case report | Dr. Edson V Cunha FIlho | Obstetrics Service, Moinhos de Vento Hospital, Brazil |
| P-075 | Poster Presentation | Preeclampsia | A survey on the diagnosis and management of uteroplacental dysfunction in hypertensive disorders of pregnancy in Japan | Dr. Kazuya Mimura | Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Japan |
| P-076 | Poster Presentation | Preeclampsia | Hypertensive disorder of pregnancy and gestational diabetes mellitus | Dr. Iroda Tojieva | Republican Specialized Scientific and Practical Medical Center of Endocrinology, Tashkent, Uzbekistan |
| P-077 | Poster Presentation | Gestational hypertension | Self-monitoring of blood pressure in women with higher risk pregnancies: the BUMP1 multicentre randomised controlled trial | Dr. Katherine L Tucker | Nuffield Department of Primary Care, The University of Oxford., UK |
| P-078 | Poster Presentation | Gestational hypertension | Profile of cesarean delivery care in hypertensive pregnant women. | Dr. Isabella Delgado | Gynecology and Obstetrics, Universidade Lusiada, Brazil |
| P-079 | Poster Presentation | Chronic hypertension | Significance of hemodynamic indices in prediction of blood pressure elevation in pregnant women with chronic hypertension | Dr. Atsushi Nakanishi | Department of obstetrics and gynecology, National Cerebral and Cardiovascular Center, Japan |
| P-080 | Poster Presentation | Chronic hypertension | A case of pheochromocytoma in pregnancy complicated with white coat hypertension | Dr. Miwa Kimura | Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Japan |
| P-081 | Poster Presentation | Chronic hypertension | Hyperaldosteronism in pregnancy : a case control study | Dr. Angela Makris | Western Sydney University, Sydney, Australia |
| P-082 | Poster Presentation | Cardiology | A systematic review of Cardiovascular Disease prevention targeting lifestyle risk factors in women. Can the evidence inform post-partum health care after hypertensive disorders of pregnancy? | Dr. Kaylee Slater | School of Health Sciences, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia |
| P-083 | Poster Presentation | Cardiology | Aortic Dissection during pregnancy: A case report | Dr. Edson V Cunha Filho | Obstetrics Service, Moinhos de Vento Hospital, Brazil |
| P-084 | Poster Presentation | Maternal mortality and morbidity | Symptomatic SARS-COV-2 infected pregnant patients and preeclampsia: worse outcome? | Dr. Lina R Marins | Gynaecology and Obstetrics Department, Hospital de Clínicas de Porto Alegre, Brazil |
| P-085 | Poster Presentation | Maternal mortality and morbidity | Should we consider Hypertensive Disordes of Pregnancy a risk factor for postpartum haemorrhage? | Dr. Sara Caamina Alvarez | Department of Obstetrics. University Hospital Ntra SRA De Candelaria. Santa Cruz Tenerife, Spain |
| P-086 | Poster Presentation | Maternal mortality and morbidity | Establishment of prediction model for hypertensive disorders of pregnancy by time series analysis | Dr. Yoshinori Moriyama | Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Japan |
| P-087 | Poster Presentation | Maternal mortality and morbidity | Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy | Dr. Mamoru Morikawa | Department of Obstetrics and Gynecology, Kansai Medical University., Japan |
| P-088 | Poster Presentation | Treatment/ management | Aspirin and the risk of birthing a small for gestational age infant; A Swedish population-based Study | Dr. Roxanne Hastie | Mercy Perinatal, Mercy Hospital for Women, Melbourne Australia |
| P-089 | Poster Presentation | Treatment/ management | SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia | Dr. Josephus F.M. van den Heuvel | University Medical Center Utrecht, The Netherlands |
| P-090 | Poster Presentation | Treatment/ management | User experiences with and recommendations for mobile health technology for hypertensive disorders of pregnancy: Mixed Methods Study | Dr. Josephus F.M. van den Heuvel | University Medical Center Utrecht, The Netherlands |
| P-091 | Poster Presentation | Treatment/ management | Ambulatory blood pressure parameters in maternal hypotension: Smooth subtype of short-term blood pressure rhythms | Dr. Wenfeng Deng | Guangzhou Women and Children's Medical Center, Guangzhou Medical University, China |
| P-092 | Poster Presentation | Treatment/ management | Implementation of angiogenic biomarkers for the diagnosis of pre-eclampsia in Greater Manchester | Dr. Emma Tomlinson | Manchester University Foundation Trust, UK |
| P-093 | Poster Presentation | Treatment/ management | Elimination of sFLT1 by therapeutic plasma exchange in early-onset preeclampsia/HELLP may improve placental dysfunction and pregnancy duration | Dr. Liyan Duan | Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany |
| P-094 | Poster Presentation | Clinical trials | Self-monitoring of blood pressure in women with pregnancy hypertension: The BUMP2 multicentre randomised controlled trial | Dr. Lucy C Chappell | School of Life Course Sciences, King's College London, UK |
| P-095 | Poster Presentation | Clinical trials | Antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia: The study protocol of a randomized phase 3 trial (KOUNO-TORI) | Dr. Shigeru Saito | University of Toyama, Toyama, Japan |
| P-096 | Poster Presentation | Late maternal consequences of Preeclampsia | Depression and anxiety in women 6 months after hypertensive pregnancy: a Blood Pressure Postpartum (BP2) sub-study | Dr. Virginia Su | School of Women’s and Children’s Health, UNSW Medicine and Health, UNSW Sydney, Australia |
| P-097 | Poster Presentation | Late maternal consequences of Preeclampsia | Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy- A qualitative rerspective | Dr. Heike Roth | Faculty of Health, University of Technology Sydney, Sydney, Australia |
| P-098 | Poster Presentation | Late maternal consequences of Preeclampsia | Motivations for reducing cardiovascular risk after hypertensive pregnancy (“not just doing this for me”): a Blood Pressure Postpartum (BP2) sub-study | Dr. Amanda Henry | School of Women's and Children's Health, The University of New South Wales, Australia |
| P-099 | Poster Presentation | Late maternal consequences of Preeclampsia | Previous preeclampsia and its association with future cardiovascular diseases: a systematic review and meta-analysis | Dr. Ricardo Cavalli | Department of Obstetrics and Gynecology, Ribeirão Preto Medical School, University of São Paulo, Brazil |
| P-100 | Poster Presentation | Late maternal consequences of Preeclampsia | Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy | Dr. Sissel Hoel | Faculty of Medicine, University of Oslo, Oslo, Norway |
| P-101 | Poster Presentation | Others | Pregnancy and infant outcomes for golimumab therapy for ulcerative colitis during the pregnancy and lactation periods: a retrospective report | Dr. Ayami Miyai | Department of Pharmacy, Kobe Medical Center, Japan |
| P-102 | Poster Presentation | Others | Fetal growth restriction as the initial findings of preeclampsia is a clinical predictor of perinatal prognosis: A single-center retrospective study | Dr. Masaya Takahashi | Department of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Japan |
| P-103 | Poster Presentation | Others | Incidence and clinical characteristics of hypotension in pregnancy | Dr. Lanlan Guo | Department of Obstetrics, Guangzhou Women and Childrens Medical Center, Guangzhou Medical University, Guangzhou, China |
| P-104 | Poster Presentation | Others | Clinical characteristics and sequelae of intrapartum hypertension | Dr. Theepika Rajkumar | Department of Medicine, Campbelltown Hospital, Campbelltown, NSW 2560, Australia |
| P-105 | Poster Presentation | Others | Probiotics supplementation increases the risk for preeclampsia | Dr. Marloes Dekker Nitert | School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia QLD 4072, Australia |
| P-106 | Poster Presentation | Others | COVID-19 and pre-eclampsia: a literature review | Dr. Heloísa T. B Moreira | Centro Universitario Lusiada, Brazil |
| P-107 | Poster Presentation | Others | Characteristics of pre-hospital care of Ppregnant women with hypertensive syndrome | Dr. Aline C. U. Intrieri | Centro Universitario Lusiada, Brazil |
| P-108 | Poster Presentation | Others | Pregnancy-associated stroke – frequency and course of subsequent pregnancies | Dr. Liisa Karjalainen | Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland |